CONTEXTVISION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6 NOK | 0.00% |
|
-0.99% | -22.08% |
| 05-08 | ContextVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-08 | Transcript : ContextVision AB, Q1 2024 Earnings Call, May 08, 2024 |
Presenter SpeechUnknown Executive (Executives)Gerald Potzsch, welcome to ContextVision. ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ContextVision AB is a Sweden-based medical technology software company specialized in image analysis and artificial intelligence. The Company is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The Company develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVisionâs cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The Company operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
Calendar
26/08/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6
NOK
Average target price
6.8
NOK
Spread / Average Target
+13.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.08% | 42.91M | |
| +9.80% | 32.94B | |
| +25.03% | 7.83B | |
| +36.69% | 4.26B | |
| -28.70% | 2.74B | |
| -20.62% | 1.39B | |
| -28.50% | 1.27B | |
| -32.48% | 1.17B | |
| +12.29% | 988M | |
| -37.86% | 884M |
- Stock Market
- Equities
- CONTX Stock
- News ContextVision AB
- Transcript : ContextVision AB, Q2 2022 Pre Recorded Earnings Call, Aug 12, 2022
